New surgery vs standard surgery for mid and lower rectal cancer
Part of Cancer, Digestive system clinical trials.
This trial compares a newer surgical approach that uses multiple imaging techniques to a standard surgery for removing rectal cancer. It aims to see if the new method leads to better outcomes for patients with middle or lower rectal cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have been diagnosed with adenocarcinoma (a common type of rectal cancer) through a biopsy
- An MRI shows the bottom edge of the tumor is below the umbilical ligament (indicating it's in the middle or lower rectum)
- CT and MRI scans do not show any signs that the cancer has spread to distant parts of the body
- Your overall health is good enough for surgery, with an ASA score of 3 or less (a standard measure of surgical risk)
- You agree to participate and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different surgery approaches for early-stage rectal cancer (T2N0M0) that is close to the anus. It tests whether a less invasive local removal followed by radiation works as well as more extensive surgery (total mesorectal excision).
This trial compares two ways of doing surgery for rectal cancer (robotic surgery versus an established non-robotic approach). It may help improve how safely and effectively rectal cancer surgery can be done for people with tumors close to the anus.
This trial compares two approaches for low-risk locally advanced rectal cancer: going straight to surgery (TME) versus receiving chemotherapy before surgery. The goal is to see if upfront surgery works just as well, sparing patients from chemotherapy side effects.
This trial tests a shorter course of radiation combined with chemotherapy and immunotherapy before surgery for high-risk rectal cancer. The goal is to see if this combination shrinks the tumor more effectively and improves outcomes.
This trial looks at whether removing the rectal tumor locally (through the anus) can work as well as a more extensive operation after scans show no remaining cancer. It may help some people avoid bigger surgery if the cancer truly appears gone after treatment.
This trial tests whether people with early- to intermediate-stage low rectal cancer can avoid surgery if their tumor responds well to a full course of chemotherapy and radiation. It starts with brief chemotherapy, then adjusts treatment based on how much the tumor shrinks.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.